Brookfield Corp’s AtriCure ATRC Stock Holding History

Brookfield Corp’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-30,937	Closed	-$2.03M	–	595
2022 Q1	$2.03M	Buy	30,937 +11,676	+61%	+$757K	0.01%	396
2021 Q4	$1.34M	Sell	19,261 -733	-4%	-$53.3K	0.01%	393
2021 Q3	$1.39M	Buy	+19,994	New	+$1.54M	0.01%	397
2021 Q1	–	Sell	-16,933	Closed	-$943K	–	463
2020 Q4	$943K	Buy	+16,933	New	+$732K	﹤0.01%	378
2020 Q3	–	Sell	-29,297	Closed	-$1.32M	–	374
2020 Q2	$1.32M	Buy	+29,297	New	+$1.28M	0.01%	263

Other funds holding ATRC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Brookfield Corp's ATRC Position: Q2 2022 in Review

Brookfield Corp sold out of AtriCure (ATRC) in Q2 2022, closing a stake of 30,937 shares — an estimated $2.03M sold.

Brookfield Corp first reported a position in ATRC in Q2 2020 and held it in 5 quarters. The position peaked at $2.03M in Q1 2022. 213 funds tracked by Wall St. Rank hold ATRC as of Q2 2022.

Brookfield Corp reported no remaining AtriCure position as of Q2 2022 after selling out during the quarter.
Brookfield Corp sold 30,937 AtriCure shares in Q2 2022, an estimated $2.03M.
Brookfield Corp first reported a position in AtriCure in Q2 2020 and held it in 5 quarters.
Brookfield Corp's AtriCure position peaked at $2.03M in Q1 2022.
213 funds tracked by Wall St. Rank held AtriCure as of Q2 2022.

Based on Brookfield Corp's 13F filing for Q2 2022, filed 15 Aug 2022.